Cargando…
Breast Cancer-Initiating Cells: Insights into Novel Treatment Strategies
There is accumulating evidence that breast cancer may arise from mutated mammary stem/progenitor cells which have been termed breast cancer-initiating cells (BCIC). BCIC identified in clinical specimens based on membrane phenotype (CD44(+)/CD24(−/low) and/or CD133(+) expression) or enzymatic activit...
Autores principales: | Santilli, Guido, Binda, Mara, Zaffaroni, Nadia, Daidone, Maria Grazia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756420/ https://www.ncbi.nlm.nih.gov/pubmed/24212666 http://dx.doi.org/10.3390/cancers3011405 |
Ejemplares similares
-
Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis
por: Venturini, Lorenza, et al.
Publicado: (2010) -
The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models
por: Cleris, Loredana, et al.
Publicado: (2019) -
[(18)F]FDG and [(18)F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer
por: Raccagni, Isabella, et al.
Publicado: (2018) -
Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients
por: Fina, Emanuela, et al.
Publicado: (2022) -
Involvement of bcl-2 and p21(waf1) proteins in response of human breast cancer cell clones to Tomudex
por: Orlandi, L, et al.
Publicado: (1999)